Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106687836 | 10668783 | 6 | F | 20141110 | 20160715 | 20141222 | 20160725 | PER | US-PFIZER INC-2014352578 | PFIZER | 65.00 | YR | F | Y | 77.00000 | KG | 20160725 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106687836 | 10668783 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG, 1X/DAY | Y | 21446 | 150 | MG | CAPSULE, HARD | QD | ||||||
| 106687836 | 10668783 | 2 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | Y | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 106687836 | 10668783 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY | Y | 21446 | 50 | MG | CAPSULE, HARD | BID | |||||
| 106687836 | 10668783 | 4 | C | CELEBREX | CELECOXIB | 1 | 200 MG, 1X/DAY | 0 | 200 | MG | QD | ||||||||
| 106687836 | 10668783 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 106687836 | 10668783 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 106687836 | 10668783 | 7 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 40 MG, DAILY | 0 | 40 | MG | |||||||||
| 106687836 | 10668783 | 8 | C | TRAMADOL. | TRAMADOL | 1 | 1 TO 2 TABLETS OF 50 MG, 3X/DAY (USUALLY TOOK TWO AT A TIME) | 0 | TABLET | TID | |||||||||
| 106687836 | 10668783 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75 ?G, DAILY | 0 | 75 | UG | |||||||||
| 106687836 | 10668783 | 10 | C | HYDROCODONE | HYDROCODONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106687836 | 10668783 | 1 | Fibromyalgia |
| 106687836 | 10668783 | 4 | Rheumatoid arthritis |
| 106687836 | 10668783 | 5 | Blood cholesterol increased |
| 106687836 | 10668783 | 6 | Abdominal discomfort |
| 106687836 | 10668783 | 7 | Depression |
| 106687836 | 10668783 | 9 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106687836 | 10668783 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106687836 | 10668783 | Abdominal distension | |
| 106687836 | 10668783 | Condition aggravated | |
| 106687836 | 10668783 | Drug hypersensitivity | |
| 106687836 | 10668783 | Dyspnoea | |
| 106687836 | 10668783 | Peripheral swelling | |
| 106687836 | 10668783 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106687836 | 10668783 | 1 | 201410 | 0 | ||
| 106687836 | 10668783 | 2 | 20141215 | 0 | ||
| 106687836 | 10668783 | 4 | 2013 | 0 | ||
| 106687836 | 10668783 | 5 | 20131101 | 0 | ||
| 106687836 | 10668783 | 10 | 201410 | 0 |